晨间信号Morning Signal
《新科学家》 第3605期 · 2026年7月25日 · 中文解读

抗病毒药物或可治疗多发性硬化症

Antivirals could help treat multiple sclerosis · Michael Le Page
约 5 分钟Health在小程序里点播,20 到 60 分钟做好
这篇讲什么
研究表明,针对EB病毒的抗病毒药物可能成为治疗多发性硬化症的有效方法。
原文开头
THE best therapy for multiple sclerosis (MS) might be antivirals that target the Epstein-Barr virus. There is strong evidence that the Epstein-Barr virus (EBV), which causes mononucleosis, or glandular fever, is also the cause of MS. But exactly how remains a mystery. The thinking has been that B-cells help drive the harmful immune response in people with MS, says Levy, and this is why drugs that reduce B-cell levels work. But the results suggest these drugs also work by eliminating EBV-infected B-cells, he says, thereby reducing the immune response caused by active viral replication. “We’re thinking that depleting B-cells is also depleting the reservoir of the Epstein-Barr virus.” Almost everyone is infected with EBV before adulthood. …
摘自《新科学家》(New Scientist)第3605期 · 2026年7月25日,Michael Le Page。仅引用开头一小段供了解文章,版权归原刊所有,全文请阅读原刊。
晨间信号小程序码
微信扫码,在小程序里听完整版
不用登录先听一篇 · 或在微信搜索小程序 晨间信号
同期其他文章